Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase |
2024-12-31 | 13G | Adagene Inc. ADAG |
Panacea Venture Healthcare Fund II, L.P. | 3,037,500 5.500% |
3,037,500 (New Position) |
Filing History |
| 2025-02-14 4:30 pm Sale |
2024-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Panacea Venture Healthcare Fund II, L.P. | 2,200,000 2.600% |
-2,000,000 (-47.62%) |
Filing History |
| 2025-02-14 4:30 pm Sale |
2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Panacea Venture Healthcare Fund II, L.P. | 0 0.000% |
-5,500,000 (Position Closed) |
Filing History |
| 2025-02-06 6:34 pm Purchase |
2025-01-30 | 13G | Atara Biotherapeutics, Inc. ATRA |
Panacea Venture Healthcare Fund II, L.P. | 550,000 9.500% |
550,000 (New Position) |
Filing History |
| 2024-11-01 8:30 pm Purchase |
2024-10-25 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Panacea Venture Healthcare Fund II, L.P. | 5,500,000 9.980% |
5,500,000 (New Position) |
Filing History |
| 2024-07-01 4:16 pm Purchase |
2024-06-27 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 13,410,000 24.300% |
1,410,000 (+11.75%) |
Filing History |
| 2024-03-11 08:44 am Purchase |
2024-03-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
Panacea Venture Healthcare Fund II, L.P. | 4,200,000 6.200% |
4,200,000 (New Position) |
Filing History |
| 2024-02-27 9:00 pm Purchase |
2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 12,000,000 21.800% |
3,100,000 (+34.83%) |
Filing History |
| 2024-02-13 4:30 pm Purchase |
2024-02-12 | 13D | Connect Biopharma Holdings Limited CNTB |
Panacea Venture Healthcare Fund II, L.P. | 8,900,000 16.200% |
8,900,000 (New Position) |
Filing History |